Atlas Trials

Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary

Clinical trial NCT02429570 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02429570
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Recurrent Brain MetastasesProgressive Brain Metastases
Start date
2015-04-22
Primary completion
2027-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.